What Does NuProbe Do?

Total employees29
HeadquartersHouston
Founded2016

NuProbe is a biotechnology company dedicated to revolutionizing molecular diagnostics. They develop and commercialize ultrasensitive and multiplexed nucleic acid detection technologies, with a primary focus on oncology, particularly liquid biopsy for cancer screening, diagnosis, and monitoring. Their proprietary Blocker Displacement Amplification (BDA) and Quantitative Amplicon Sequencing (QASeq) technologies enable the detection of rare genetic variants with high accuracy and sensitivity. NuProbe aims to improve patient outcomes by providing innovative tools for early disease detection and personalized medicine. The company has operations in both the USA and China, addressing global healthcare needs.

Where Is NuProbe's Headquarters?

HQ Function

The Houston headquarters serves as the central node for global corporate strategy, research and development leadership, business development, strategic partnerships, and administrative functions for North American operations.

Notable Features:

Located within JLABS @ TMC, part of the Texas Medical Center, offering access to state-of-the-art laboratory facilities, shared equipment, and a vibrant collaborative environment designed to accelerate biotech innovation.

Work Culture:

The work culture at NuProbe's Houston HQ is likely dynamic, science-driven, and entrepreneurial, fostering innovation, collaboration among multidisciplinary teams, and a strong focus on translating research into impactful diagnostic solutions.

HQ Significance:

Houston's Texas Medical Center ecosystem provides NuProbe with unparalleled access to world-class research institutions, clinical collaborators, a skilled talent pool, and venture capital, crucial for a company at the forefront of diagnostic technology development.

Values Reflected in HQ: The HQ's location and setup reflect NuProbe's commitment to scientific excellence, innovation, collaboration, and speed in developing and delivering advanced diagnostic technologies to patients.

Location:

NuProbe maintains a significant global presence with key operational hubs in Houston, Texas, USA, and in Shanghai and Suzhou, China. These locations support comprehensive functions including research and development, manufacturing, clinical validation, and commercial activities. This strategic distribution allows NuProbe to tap into diverse talent pools, access leading scientific and medical ecosystems, and cater to the specific needs of both Western and Eastern healthcare markets, driving the global adoption of its innovative molecular diagnostic technologies.

Street Address:

2450 Holcombe Blvd, Suite X

City:

Houston

State/Province:

Texas

Country:

USA

Where Else Does NuProbe Operate Around the World?

Shanghai, China

Address: Building 7, Lane 1188, Tianxiong Road, Minhang District, Shanghai, China

To leverage local scientific talent, address the specific healthcare needs of the region, facilitate local regulatory processes, and drive commercialization efforts in the rapidly growing Asian molecular diagnostics market.

Suzhou, Jiangsu Province, China

Address: BioBay, Suzhou Industrial Park, Suzhou, Jiangsu, China

To provide scalable, high-quality manufacturing capabilities, ensuring cost-effective production and reliable supply of NuProbe's products to meet increasing global demand, particularly within Asia.

Buying Intent Signals for NuProbe

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading NuProbe? Meet the Executive Team

As of April 2025, NuProbe' leadership includes:

Yingshuang Chai, Ph.D. - Co-Founder & Chief Executive Officer
David Yu Zhang, Ph.D. - Co-Founder & Head of Innovation
Peng Dai, Ph.D. - Co-Founder & Head of R&D, Shanghai
Hsueh-Fu Fred Wu, MBA - Chief Financial Officer
Stephen Lincoln - Vice President of Operations and Quality
Lixin Zhou, Ph.D. - Vice President of Business Development

Who's Investing in NuProbe?

NuProbe has been backed by several prominent investors over the years, including:

Sequoia Capital China
CR-CP Life Science Fund
Panacea Venture
BioTrack Capital
YuanBio Venture Capital
GTJA Investment Group
Lapam Capital
Puhua Capital

What Leadership Changes Has NuProbe Seen Recently?

Hire1
Exits0

NuProbe strengthened its executive leadership in the past year with a key hire in business development to drive strategic growth. No major executive departures have been publicly announced, indicating stability in the core leadership team.

New Appointments:

Lixin Zhou, Ph.D., Lixin Zhou, Ph.D., was appointed Vice President of Business Development, bringing extensive experience to enhance NuProbe's strategic alliances and commercial outreach.

What Technology (Tech Stack) Is Used byNuProbe?

Discover the tools NuProbe uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

NuProbe Email Formats and Examples

NuProbe likely utilizes standard corporate email address formats. Common patterns for technology and biotech companies include combinations of first name, last name, and initials. For NuProbe, the most probable formats are [first_initial][last]@nuprobe.com or [first].[last]@nuprobe.com. The success rate in guessing these formats for outreach can be moderately high, especially for general inquiries or publicly listed individuals.

NuProbe's common email formats include fLast@nuprobe.com (e.g., jdoe@nuprobe.com) and first.last@nuprobe.com (e.g., jane.doe@nuprobe.com).

Format

lzhou@nuprobe.com

Example

75%

Success rate

What's the Latest News About NuProbe?

Business WireMarch 13, 2024

NuProbe and Agena Bioscience Announce Strategic Partnership for Ultrasensitive Cancer Assays

NuProbe entered a strategic partnership with Agena Bioscience to co-develop and commercialize ultrasensitive cancer assays. The collaboration aims to combine NuProbe's Blocker Displacement Amplification (BDA) technology with Agena's MassARRAY System to enhance liquid biopsy capabilities for oncology applications....more

NuProbe Website NewsJuly 20, 2023

NuProbe's Novel Quantitative Hotspot SNP Mutation Detection Method Published in Nature Biomedical Engineering

NuProbe announced the publication of its research on a novel quantitative hotspot SNP mutation detection method in the prestigious journal Nature Biomedical Engineering. The study showcased the capabilities of its Blocker Displacement Amplification (BDA) technology for highly sensitive and accurate detection of low-frequency genetic variants....more

NuProbe Website NewsApril 6, 2023

NuProbe Presents Data Validating Ultrasensitive Liquid Biopsy Assays at AACR Annual Meeting 2023

NuProbe announced it would present significant data at the American Association for Cancer Research (AACR) Annual Meeting 2023. The presentations validated its ultrasensitive liquid biopsy assays for detecting low-frequency cancer mutations, highlighting the technology's potential in early cancer detection and disease monitoring....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including NuProbe, are just a search away.